Media coverage
11
Media coverage
Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia; - Zodasiran significantly reduced triglycerides and atherogenic triglyceride rich lipoproteins across all dose levels at Week 24; - Data presented at E Media name/outlet Business Wire Country/Territory United States Date 29/05/24 Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet Morningstar.com Country/Territory United States Date 29/05/24 URL ct.moreover.com/?a=53926998554&p=1gw&v=1&x=_RXAKgZ8soksf8Rupf_ktw Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet BioSpace Country/Territory United States Date 29/05/24 URL ct.moreover.com/?a=53927462200&p=1gw&v=1&x=Gl0YMuj5x_smaQJEXX9BWQ Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet InvestorsObserver Country/Territory United States Date 29/05/24 URL ct.moreover.com/?a=53926921325&p=1gw&v=1&x=HgR1VWpl9BfnFz9ftEEjkQ Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet Yahoo! Finanzas Country/Territory United States Date 29/05/24 URL ct.moreover.com/?a=53926957371&p=1gw&v=1&x=YCWq0Ed1xEo6eJp00wDWhA Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet Yahoo! Finance Country/Territory United States Date 29/05/24 URL ct.moreover.com/?a=53927035925&p=1gw&v=1&x=47ehM4UnKmW7fT6hvEsd-g Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet APNews.com Country/Territory United States Date 29/05/24 URL ct.moreover.com/?a=53926973660&p=1gw&v=1&x=4w2I3yBndsykszJMMtHYoQ Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet Stockwatch Country/Territory Canada Date 29/05/24 URL ct.moreover.com/?a=53926930112&p=1gw&v=1&x=bB9vobPbeNGbSlNZKUO99g Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet Wallstreet Online Country/Territory Germany Date 29/05/24 URL ct.moreover.com/?a=53926942495&p=1gw&v=1&x=UyqK434d8yr9SA8Xqksmjg Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet Crwe World Country/Territory United States Date 29/05/24 URL ct.moreover.com/?a=53927035932&p=1gw&v=1&x=P-OWDR6sqq3FQvfr5O3Ibg Persons Robert Sidney Rosenson Title Arrowhead Pharmaceuticals, Inc.: Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 29/05/24 URL ct.moreover.com/?a=53926992214&p=1gw&v=1&x=nhK5vBQtTckJuHtlBvfW2A Persons Robert Sidney Rosenson